P

Inventor

BURY PAUL STANLEY

DK33 patents
⚠️ This page may combine multiple inventors who share the name “BURY PAUL STANLEY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVO NORDISK AS

30 patents
US6602901B2Aug 5, 2003

Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

NOVO NORDISK AS14 citations93
US6468996B1Oct 22, 2002

Substituted hetero-polycyclic compounds as PPARα and PPARγ activators

NOVO NORDISK AS33 citations93
US6248781B1Jun 19, 2001

Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

NOVO NORDISK AS26 citations93
US7202213B2Apr 10, 2007

Combination therapy using a dual PPAR-α/PPAR-γ activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders

NOVO NORDISK AS21 citations92
US7067530B2Jun 27, 2006

Compounds, their preparation and use

NOVO NORDISK AS22 citations92
US6869967B2Mar 22, 2005

Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives

NOVO NORDISK AS26 citations92
US6569901B2May 27, 2003

Alkynyl-substituted propionic acid derivatives, their preparation and use

NOVO NORDISK AS33 citations92
US6555577B1Apr 29, 2003

Compounds, their preparation and use

NOVO NORDISK AS28 citations92
US6316494B1Nov 13, 2001

cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

NOVO NORDISK AS36 citations92
US6274608B1Aug 14, 2001

Compounds, their preparation and use

NOVO NORDISK AS23 citations92
US6043269AMar 28, 2000

cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

NOVO NORDISK AS38 citations92
US5985306ANov 16, 1999

(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes

NOVO NORDISK AS35 citations92
US5958967ASep 28, 1999

Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

NOVO NORDISK AS26 citations92
US5919817AJul 6, 1999

Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

NOVO NORDISK AS28 citations92
US7220877B2May 22, 2007

Compounds, their preparation and use

NOVO NORDISK AS12 citations84
US6972294B1Dec 6, 2005

Compounds, their preparation and use

NOVO NORDISK AS18 citations84
US6867218B2Mar 15, 2005

Compounds, their preparation and use

NOVO NORDISK AS17 citations84
US6214820B1Apr 10, 2001

Compounds, their preparation and use

NOVO NORDISK AS15 citations84
US6353018B1Mar 5, 2002

Compounds, their preparation and use

NOVO NORDISK AS9 citations74
US6723731B2Apr 20, 2004

Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

NOVO NORDISK AS2 citations63
US6534517B2Mar 18, 2003

Compounds, their preparation and use

NOVO NORDISK AS2 citations63
US6369055B1Apr 9, 2002

Compounds, their preparation and use

NOVO NORDISK AS4 citations63
US6300339B1Oct 9, 2001

Compounds, their preparation and use

NOVO NORDISK AS5 citations63
US6080754AJun 27, 2000

Pyrrolo[2,1,5-cd]indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

NOVO NORDISK AS2 citations62
US6703401B2Mar 9, 2004

Compounds, their preparation and use

NOVO NORDISK AS0 citations52
US6683111B2Jan 27, 2004

Compounds, their preparation and use

NOVO NORDISK AS1 citations52
US6525086B2Feb 25, 2003

Compounds, their preparation and use

NOVO NORDISK AS0 citations52
US6509374B2Jan 21, 2003

Compounds, their preparation and use

NOVO NORDISK AS1 citations52
US6407127B2Jun 18, 2002

Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)

NOVO NORDISK AS0 citations52
US6365586B1Apr 2, 2002

Compounds, their preparation and use

NOVO NORDISK AS1 citations52

NOVO NORDISK

2 patents

BURY PAUL STANLEY

1 patent